TRESIBA 100IU FLEX TOUCH PEN(PREFILLED) contains
Insulin Degludec
, which belongs to a group of medicines called Antidiabetics. TRESIBA 100IU FLEX TOUCH PEN(PREFILLED) is used to manage diabetes mellitus (high blood sugar) in adults, adolescents, and children (aged 1 year and above).
TRESIBA 100IU FLEX TOUCH PEN(PREFILLED) is also used in combination with oral or other injectable antidiabetic medicines to manage type 2 diabetes mellitus. The medicine is also indicated for use to manage type 1 diabetes mellitus when used in combination with meal-related rapid-acting insulin medicines in affected individuals.
Before administering TRESIBA 100IU FLEX TOUCH PEN(PREFILLED), inform your doctor if you have abnormally low or high blood sugar levels, eye disorders, poor eyesight, liver, and/or kidney problems.
TRESIBA 100IU FLEX TOUCH PEN(PREFILLED) should be used with caution during pregnancy and by women planning for pregnancy. It is also advised to be administered with caution to breastfeeding women.
TRESIBA 100IU FLEX TOUCH PEN(PREFILLED) should be used with caution in children and adolescents (aged 1 to 18 years) and is advised to be used with caution in elderly patients (aged 65 years and above) after consulting your doctor.
The most common side effects associated with the use of TRESIBA 100IU FLEX TOUCH PEN(PREFILLED) are low blood sugar levels (associated with symptoms such as sweating, tiredness, dizziness, and/or feeling increased hunger) and injection site reactions (such as pain, redness, itchy welts, swelling, and/or itching). Consult your doctor if any of these symptoms worsen.
No content available